Michael Jude Loquasto - 18020 Bethlehem, PA

Business Name: Michael Jude Loquasto
Categorized In: Doctors
Address: 2571 Baglyos Circle # B27, Bethlehem, PA 18020
Phone Number: (484) 821-1460
Contact Person: Michael Loquasto, Owner
Website Address: drmichaelloquasto.com
NAICS Code: 6213100
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2009
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Finegan Jr James T MD - Bethlehem, PA 18020
Scoblionko David P MD - Bethlehem, PA 18020
Wilson Deborah J DO - Bethlehem, PA 18020
Norelli Charles C MD - Bethlehem, PA 18020
Jay S Riccardi Md - Bethlehem, PA 18020
Surgical Specialty Center - Bethlehem, PA 18020
Benjamin J Quintana M D - Bethlehem, PA 18020
Brislin Kenneth J MD - Bethlehem, PA 18020
Brau Alan S MD - Bethlehem, PA 18020
Desousa Hansel H MD - Bethlehem, PA 18020
Hernandez Jon D MD - Bethlehem, PA 18020
Fineman Mitchell S MD - Bethlehem, PA 18020
Sexton Scott E MD - Bethlehem, PA 18020
Singh Vasu MD - Bethlehem, PA 18020
Salem Mohamed I MD - Bethlehem, PA 18020
George Sean K DO - Bethlehem, PA 18020
Furlong-Julia Ellen M MD - Bethlehem, PA 18020
Gonzalez Rene M MD - Bethlehem, PA 18020
Arora Rajeev K MD - Bethlehem, PA 18020
Pham Vincent MD - Bethlehem, PA 18020

Michael Jude Loquasto provides professional Doctors from its single location at the coordinates 40.65877,-75.2971.

The company offers B2C variables under the SIC code 8011 and NAICS code 6213100, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2009, the company can now be visited at 2571 Baglyos Circle # B27, Bethlehem, Pennsylvania 18020 or contacted through representative Michael Loquasto, Owner at (484) 821-1460.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Michael Jude Loquasto through its company website at drmichaelloquasto.com. Engage with this business on its social media platforms through on Twitter and on Facebook.